Trial Profile
Efficacy of a loading dose of atorvastatin for the prevention of major adverse cardiac events in patients with non-ST segment elevation acute coronary syndromes, undergoing percutaneous coronary intervention.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 17 Mar 2011
Price :
$35
*
At a glance
- Drugs Atorvastatin (Primary)
- Indications Myocardial infarction
- Focus Therapeutic Use
- 17 Mar 2011 New trial record